Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2025-02-11FDA Approved: PEPCID COMPLETE — Supplemental Application (Lil' Drug Store Products, Inc.)
The FDA approved a supplemental application for Pepcid Complete, a chewable tablet combining famotidine with calcium carbonate and magnesium…
-
FDA label_change · 2025-01-31FDA Approved: PEPCID COMPLETE — Supplemental Application (Lil' Drug Store Products, Inc.)
FDA approved a supplemental application for Pepcid Complete chewable tablets (famotidine with calcium carbonate and magnesium hydroxide) sub…
-
CLINICAL_TRIALS research · 2025-01-31Clinical Trial Update: Primary carE PPi dEprescRibing Trial [Phase 4]
Phase 4 deprescribing trial at KU Leuven evaluating stopping or reducing proton pump inhibitors in patients with heartburn, dyspepsia, and g…
-
CLINICAL_TRIALS research · 2025-01-27Clinical Trial Update: Neuroregulators for the Treatment of Diseases Associated With Esophageal-brain-gut Axis Communication Abnormalities. [NA]
A recruiting clinical trial from Hualien Tzu Chi General Hospital is evaluating neuroregulators for diseases associated with esophageal-brai…
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: Study to Evaluate the Efficacy and Safety of FEXUCLUE Tablet
A completed study evaluating the efficacy and safety of FEXUCLUE Tablet for gastroesophageal reflux disease.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE Tab
A completed clinical trial evaluating the improvement of subjective symptoms with FEXUCLUE Tab in gastroesophageal reflux disease.
-
FDA approval · 2025-01-17FDA Approved: PEPCID COMPLETE — Supplemental Application (Lil' Drug Store Products, Inc.)
The FDA approved a supplemental application to authorize Pepcid Complete chewable tablets (famotidine with calcium carbonate and magnesium h…
-
FDA approval · 2025-01-16FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved the original abbreviated new drug application for pantoprazole sodium from Rising Pharma Holdings, enabling the generic pro…
-
CLINICAL_TRIALS research · 2025-01-14Clinical Trial Update: Evaluation of Upper Esophageal Sphincter Motor Activity in Patients with Extra Esophageal Reflux Symptoms
This clinical trial update reports on the evaluation of upper esophageal sphincter motor activity in patients with extraesophageal reflux sy…
-
CLINICAL_TRIALS trial_result · 2025-01-10Clinical Trial Update: Effect of Obesity on Proton Pump Inhibitors [Phase 4]
Phase 4 trial completed evaluating whether obesity affects the use or effectiveness of proton pump inhibitors in obesity with NAFLD and GERD…
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: Stretta Versus Conservative Treatment [NA]
A clinical trial comparing the Stretta procedure to conservative treatment for gastroesophageal reflux disease is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-01-03Clinical Trial Update: One Anastomosis Gastric Bypass With Excluded Stomach Fundoplication: FundoRing vs Nissen vs OAGB Without Fundoplication [NA]
A completed clinical trial comparing FundoRing (one-anastomosis gastric bypass with excluded stomach fundoplication), Nissen fundoplication,…
-
CLINICAL_TRIALS research · 2025-01-03Clinical Trial Update: Role of Mucosal Impedance Measurement for the Diagnosis of Gastroesophageal Reflux Disease
A clinical trial investigating mucosal impedance measurement as a diagnostic tool for gastroesophageal reflux disease is currently recruitin…
-
FDA approval · 2024-12-19FDA Approved: LANSOPRAZOLE — Supplemental Application (Medcore LLC)
The FDA approved a supplemental application for lansoprazole from Medcore LLC, enabling a generic lansoprazole product to be marketed under …
-
FDA approval · 2024-12-19FDA Approved: LANSOPRAZOLE — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for lansoprazole submitted by NorthStar Rx LLC.
-
CLINICAL_TRIALS trial_result · 2024-12-19Clinical Trial Update: A Study to Evaluate Vonoprazan in Children Who Have Symptomatic Gastroesophageal Reflux Disease [Phase 1]
Phase 1 trial evaluating vonoprazan in children with symptomatic gastroesophageal reflux disease has completed and results have been posted.
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: Preserving the Pre-cardial Fat Pad During Sleeve Gastrectomy on Postoperative Gastroesophageal Reflux [NA]
A clinical trial is exploring whether preserving the pre-cardial fat pad during sleeve gastrectomy influences postoperative gastroesophageal…
-
FDA approval · 2024-12-10FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for esomeprazole magnesium from Ascend Laboratories, LLC, under an approved ANDA.
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: Clinical Study Evaluating The Role of Vonoprazan Versus Pantoprazole in Patients With Gastroesophageal Reflux Disease [Phase 4]
Phase 4 clinical trial comparing vonoprazan with pantoprazole in gastroesophageal reflux disease; the study is currently recruiting.
-
FDA approval · 2024-11-27FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for pantoprazole sodium from Amneal Pharmaceuticals LLC, updating the approval for this generic prot…
-
CLINICAL_TRIALS research · 2024-11-22Clinical Trial Update: Barrett's Esophagus Related Neoplasia (BERN) Project
This ClinicalTrials.gov entry indicates the Barrett's Esophagus Related Neoplasia (BERN) Project is currently recruiting to study Barrett's …
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests
This entry reports a recruiting clinical trial studying patient preferences for Barrett's esophagus and esophageal cancer screening tests.
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: Anti-reflux Mucosal Valvuloplasty Versus PPIs for GERD Treatment [NA]
This clinical trial update indicates a study comparing anti-reflux mucosal valvuloplasty to proton pump inhibitors for gastroesophageal refl…
-
CLINICAL_TRIALS research · 2024-11-14Clinical Trial Update: The Role of Laryngopharyngeal Reflux in IPF
This clinical trial at National Jewish Health investigates the role of laryngopharyngeal reflux in idiopathic pulmonary fibrosis and related…
-
CLINICAL_TRIALS trial_result · 2024-11-13Clinical Trial Update: Effect of Two Different Doses of Neostigmine on the Gastric Residual Volume and Aspiration in Critically Ill Patients
A completed clinical trial comparing two doses of neostigmine to assess effects on gastric residual volume and aspiration risk in critically…